Elicio Therapeutics, Inc. 13D and 13G filings for Angion Biomedica Corp.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-04-27 4:10 pm Sale | 2021-12-31 | 13G | Angion Biomedica Corp. ANGN | Elicio Therapeutics Inc. ELTX | 181,512 6.000% | -108,662 (-37.45%) | Filing |
| 2022-04-27 4:08 pm Purchase | 2021-02-04 | 13D | Angion Biomedica Corp. ANGN | Elicio Therapeutics Inc. ELTX | 290,174 9.300% | 290,174 (New Position) | Filing |